Enhanced data sharing and coordination to ensure Australia can address the threat of extensively drug-resistant Shigella – a case study for consideration by the Australian Centre for Disease Control
DOI:
https://doi.org/10.33321/cdi.2025.49.064Keywords:
shigellosis, surveillance, antimicrobial resistanceAbstract
Increasing antimicrobial resistance and changing epidemiological risk groups for shigellosis pose a threat to Australian public health. Integrated surveillance, enhanced through pathogen genomics data, represents an opportunity to improve the precision of public health responses to drug-resistant shigellosis in Australia and a compelling case study for the new Australian Centre for Disease Control. Here we describe a national public health laboratory scoping study and propose a model for enhanced surveillance of shigellosis that will improve national responses to this emerging public health threat.
Downloads
References
Food Standards Australia New Zealand (FSANZ). Shigella species. Canberra: FSANZ; December 2013. Available from: https://www.foodstandards.gov.au/sites/default/files/publications/Documents/Shigella%20species%20-%20dec%202013.pdf.
Therapeutic Guidelines Limited. Acute infectious diarrhoea – Shigella enteritis (shigellosis). [Webpage.] Melbourne: Therapeutic Guidelines Limited; 2019. Available from: https://tgldcdp.tg.org.au/viewTopic?topicfile=acute-gastroenteritis&guidelineName=Antibiotic#abg16-c22-s18.
Baker S, The HC. Recent insights into Shigella. Curr Opin Infect Dis. 2018;31(5):449–54. doi: https://doi.org/10.1097/QCO.0000000000000475.
Mason LCE, Greig DR, Cowley LA, Partridge SR, Martinez E, Blackwell GA et al. The evolution and international spread of extensively drug resistant Shigella sonnei. Nat Commun. 2023;14(1):1983. doi: https://doi.org/10.1038/s41467-023-37672-w.
Australian Commission on Quality and Safety in Healthcare (ACSQHC). CARAlert annual report: 2023. Canberra: ACSQHC; May 2024. Available from: https://www.safetyandquality.gov.au/publications-and-resources/resource-library/caralert-annual-report-2023.
Williamson D, Ingle D, Howden B. Extensively drug-resistant shigellosis in Australia among men who have sex with men. N Engl J Med. 2019;381(25):2477–9. doi: https://doi.org/10.1056/NEJMc1910648.
Ingle DJ, Andersson P, Valcanis M, Barnden J, Gonçalves da Silva A, Horan KA et al. Prolonged outbreak of multidrug-resistant Shigella sonnei harboring bla(CTX-M-27) in Victoria, Australia. Antimicrob Agents Chemother. 2020;64(12):e01518-20. doi: https://doi.org/10.1128/AAC.01518-20.
World Health Organization (WHO). Disease Outbreak News: Extensively drug resistant Shigella sonnei infections – Europe – European Region (EURO). [Media release.] Geneva: WHO; 24 March 2022. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON364.
Australian Government Department of Health, Disability and Ageing, Public Health Laboratory Network. Shigelloisis – Laboratory case definition. [Webpage.] Canberra: Australian Government Department of Health, Disability and Ageing; 29 May 2000. Available from: https://www.health.gov.au/resources/publications/shigellosis-laboratory-case-definition.
Victorian State Government Department of Health (Victoria Health). Shigellosis – management recommendations updated. [Media release.] Melbourne: Victoria Health; 11 April 2019. Available from: https://www.health.vic.gov.au/health-advisories/shigellosis-management-recommendations-updated.
New South Wales State Government Department of Health (NSW Health). Increase in antibiotic resistant Shigella. [Media release.] Sydney: NSW Health; 31 March 2013. Available from: https://www.health.nsw.gov.au/Infectious/alerts/Pages/shigella-drug-resistance.aspx.
Lane CR, Sherry NL, Porter AF, Duchene S, Horan K, Andersson P et al. Genomics-informed responses in the elimination of COVID-19 in Victoria, Australia: an observational, genomic epidemiological study. Lancet Public Health. 2021;6(8):e547–56. doi: https://doi.org/10.1016/S2468-2667(21)00133-X.
Hoang T, Gonçalves da Silva A, Jennison AV, Williamson DA, HowdenBP, Seemann T. AusTrakka: fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic. Nat Commun. 2022;13(1):865. doi: https://doi.org/10.1038/s41467-022-28529-9.
Webb JR, Andersson P, Sim E, Zahedi A, Donald A, Hoang T et al. Implementing a national programme of pathogen genomics for public health: the Australian Pathogen Genomics Program (AusPathoGen). Lancet Microbe. 2025;6(3):100969. doi: https://doi.org/10.1016/j.lanmic.2024.100969.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
